Physician profile
Julio Hernandez
NPI 1629071907
$1,912.43
in general payments reported to CMS, 2019-2025
21 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $38.64 · 2021: $193 · 2022: $255 · 2023: $308 · 2024: $798 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,275.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $605.25 | 2023-2024 | Xifaxan |
| Abbvie INC. | $301.42 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $218.56 | 2021-2024 | Dupixent |
| Lilly USA, LLC | $123.60 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Novartis Pharmaceuticals Corporation | $95.26 | 2019-2021 | |
| Janssen Biotech, INC. | $87.50 | 2022-2024 | Tremfya, Remicade, Stelara |
| Sun Pharmaceutical Industries INC. | $76.75 | 2021-2025 | |
| Ucb, INC. | $66.12 | 2021-2022 | |
| Leo Pharma INC. | $39.42 | 2020-2022 | |
| Encore Medical, LP | $38.74 | 2023 | Djo Surgical |
| Arcutis Biotherapeutics, INC. | $36.83 | 2024-2025 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $35.18 | 2023 | Jublia |
| Amgen INC. | $33.97 | 2023-2025 | Otezla, Otezla |
| Integra Lifesciences Corporation | $28.66 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Incyte Corporation | $27.59 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $23.59 | 2019 | |
| Botanix Sb INC | $19.61 | 2025 | Sofdra |
| Lnhc, INC | $17.83 | 2025 | Zelsuvmi |
| Paratek Pharmaceuticals, INC. | $17.53 | 2025 | Nuzyra |
| Mimedx Group, INC. | $14.90 | 2025 | |
| Mayne Pharma Commercial LLC | $4.12 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julio Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.